✦ LIBER ✦

A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines

✍ Scribed by George Orphanos; Athanasios Alexopoulos; Savvoula Malliou; George Ioannidis; Alexandros Ardavanis; Constantinos Kandylis; John Stavrakakis; Gerassimos Rigatos

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 312 KB
Volume: 136
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-009-0642-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oral vinorelbine in co

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

✍ Alison Jones; Mary O’Brien; Harald Sommer; Elzbieta Nowara; Anja Welt; Tadeusz P 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 364 KB

Gemcitabine and vinorelbine as second-li

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB

Phase II, double-blind, randomized trial

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

✍ Mark Clemons; Anil A. Joy; Radhi Abdulnabi; Mauricio Kotliar; Jodi Lynch; Johan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 317 KB

An all-oral combination of metronomic cy

An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study

✍ Zhonghua Wang; Jingsong Lu; Shiangjiin Leaw; Xiaonan Hong; Jialei Wang; Zhimin S 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 223 KB

Phase II study of capecitabine and trast

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

✍ Takanori Ishida; Takayoshi Kiba; Motohiro Takeda; Kotone Matsuyama; Satoshi Tera 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 367 KB

Phase II study of capecitabine combined

Phase II study of capecitabine combined with gemcitabine in the treatment of androgen-independent prostate cancer previously treated with taxanes

✍ Alan Rodney; Pauline Dieringer; Paul Mathew; Eric Jonasch; Nizar Tannir; Lance C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract ## BACKGROUND The primary objective of the current study was to evaluate the effectiveness of capecitabine and gemcitabine in the treatment of patients with androgen‐independent prostate cancer (AIPCa) who experienced disease progression after taxane therapy. The secondary objective wa